CO9 A Real-World Examination of HBA1C Reduction and Target Achievement Comparing SGLT2 Inhibitors and GLP1 Receptor Agonists As Second-Line Augmentation to Metformin for Treating Type II Diabetes
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.083
https://www.valueinhealthjournal.com/article/S1098-3015(23)00183-3/fulltext
Title :
CO9 A Real-World Examination of HBA1C Reduction and Target Achievement Comparing SGLT2 Inhibitors and GLP1 Receptor Agonists As Second-Line Augmentation to Metformin for Treating Type II Diabetes
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00183-3&doi=10.1016/j.jval.2023.03.083
First page :
Section Title :
Open access? :
No
Section Order :
10264